| Indicators | Browse All

Claritev Corporation (CTEV)

Healthcare | Health Information Services | McLean, United States | NYSE
28.74 USD +0.23 (0.807%) ⇧ (July 15, 2026, 9:51 a.m. EDT)

Short-term:★★⯪☆☆Long-term:★☆☆☆☆Dividends:☆☆☆☆☆
Hot Take | July 11, 2026, 3:53 a.m. EDT

The investment case here is fraught with severe structural damage. The company is hemorrhaging value, trading at a forward P/E of 4.5x despite generating negative earnings and reporting a -29% profit margin. The balance sheet is a ticking time bomb, carrying nearly $4.7 billion in debt against a market cap of only $532 million, creating a precarious solvency risk. While the stock recently rallied 213% year-over-year, this was a recovery from a catastrophic 89% decline over the last five years, leaving the asset deeply scarred. The lack of any dividend history confirms the capital is being consumed by operations and debt servicing. Although the stock is technically cheap compared to its 52-week high, the widening net loss and the looming debt wall suggest this is a value trap rather than a bargain. The recent price action shows some stabilization, but the fundamental deterioration makes holding this position highly dangerous.

Model Selection — Backtest MAE (log-scale, lower is better)
ModelMAE
AutoTheta ✓0.139320
MSTL0.157075
AutoETS0.158728
AutoARIMA0.200678

Forecast horizon: 45 days | Selected: AutoTheta

Forecast Reliability
Score 24%
H-stat 0.15
Ljung-Box p 0.000
Jarque-Bera p 0.000
Excess Kurtosis 3.61
Attribute Value
Sector Healthcare
Revenue per Share 59.177
Market Cap 489,953,408
Forward P/E 4.20
Beta 0.70
Profit Margins -29.27%
Previous Name Churchill Capital Corp III
Website https://www.claritev.com

As of July 11, 2026, 3:53 a.m. EDT: Speculators are heavily positioned for downside protection, with massive open interest in deep out-of-the-money puts (strikes 10 and 15) expiring in July and August, suggesting a fear of a significant drop. Conversely, call activity is concentrated in the money and moderately out-of-the-money strikes (30-40), indicating a belief that the stock will recover from its lows rather than crash further. However, the sheer volume of put open interest relative to call open interest at near-term expirations highlights a defensive bias among traders.


Info Dump

Attribute Value
52 Week Change -0.35691607
Address1 7,900 Tysons One Place
Address2 Suite 400
All Time High 517.2
All Time Low 4.8
Ask 29.5
Ask Size 200
Audit Risk 4
Average Daily Volume10 Day 101,300
Average Daily Volume3 Month 148,267
Average Volume 148,267
Average Volume10Days 101,300
Beta 0.7
Bid 27.96
Bid Size 700
Board Risk 8
Book Value -14.184
City McLean
Compensation As Of Epoch Date 1,767,139,200
Compensation Risk 10
Country United States
Crypto Tradeable 0
Currency USD
Current Price 28.74
Current Ratio 1.278
Custom Price Alert Confidence HIGH
Date Short Interest 1,782,777,600
Day High 28.74
Day Low 28.73
Display Name Claritev
Earnings Call Timestamp End 1,778,155,200
Earnings Call Timestamp Start 1,778,155,200
Earnings Timestamp 1,778,157,000
Earnings Timestamp End 1,786,019,400
Earnings Timestamp Start 1,786,019,400
Ebitda 533,342,016
Ebitda Margins 0.54492
Enterprise To Ebitda 9.762
Enterprise To Revenue 5.319
Enterprise Value 5,206,483,456
Eps Current Year 5.58
Eps Forward 6.84
Eps Trailing Twelve Months -16.47
Esg Populated 0
Exchange NYQ
Exchange Data Delayed By 0
Exchange Timezone Name America/New_York
Exchange Timezone Short Name EDT
Fifty Day Average 27.6698
Fifty Day Average Change 1.0702
Fifty Day Average Change Percent 0.038677547
Fifty Two Week Change Percent -35.69161
Fifty Two Week High 74.07
Fifty Two Week High Change -45.33
Fifty Two Week High Change Percent -0.61198866
Fifty Two Week Low 11.5
Fifty Two Week Low Change 17.24
Fifty Two Week Low Change Percent 1.4991304
Fifty Two Week Range 11.5 - 74.07
Financial Currency USD
First Trade Date Milliseconds 1,585,920,600,000
Float Shares 5,756,015
Forward Eps 6.84
Forward P E 4.201754
Free Cashflow 108,931,752
Full Exchange Name NYSE
Full Time Employees 3,000
Gmt Off Set Milliseconds -14,400,000
Governance Epoch Date 1,782,864,000
Gross Margins 0.73226
Gross Profits 716,705,984
Has Pre Post Market Data 1
Held Percent Insiders 0.07445
Held Percent Institutions 0.91019
Implied Shares Outstanding 17,047,789
Industry Health Information Services
Industry Disp Health Information Services
Industry Key health-information-services
Is Earnings Date Estimate 1
Language en-US
Last Fiscal Year End 1,767,139,200
Last Split Date 1,727,049,600
Last Split Factor 1:40
Long Business Summary Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers claims intelligence solutions, including reference-based pricing, negotiation services, surprise bill services, and Vistara; network solutions, such as primary networks, complementary networks, and network build and network management services; and payment and revenue integrity solutions comprising clinical negotiation, pre-payment integrity, post-payment integrity, and revenue integrity services. It also provides data and analytics solutions consists of PlanOptix, CompleteVue, BenInsights, risk scores, and supplemental carrier services. The company provides solutions to commercial healthcare payers, third party administrators, employers, brokers/consultants, providers, government healthcare payers and system integrators. It serves national and regional insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, TPAs, property and casualty insurers, bill review companies and other companies involved in the claims adjudication process. The company was formerly known as MultiPlan Corporation and changed its name to Claritev Corporation in February 2025. Claritev Corporation was founded in 1980 and is headquartered in McLean, Virginia.
Market us_market
Market Cap 489,953,408
Market State REGULAR
Max Age 86,400
Message Board Id finmb_968903
Most Recent Quarter 1,774,915,200
Name Change Date 2,026-07-15
Net Income To Common -286,523,008
Next Fiscal Year End 1,798,675,200
Non Diluted Market Cap 483,475,296
Number Of Analyst Opinions 6
Open 27.93
Operating Cashflow 101,601,000
Operating Margins 0.07547
Overall Risk 9
Payout Ratio 0.0
Phone 212 780 2000
Prev Name Churchill Capital Corp III
Previous Close 28.51
Price Eps Current Year 5.1505375
Price Hint 2
Price To Book -2.0262268
Price To Sales Trailing12 Months 0.5005853
Profit Margins -0.29274
Quick Ratio 0.926
Quote Source Name Nasdaq Real Time Price
Quote Type EQUITY
Recommendation Key none
Region US
Regular Market Change 0.22999954
Regular Market Change Percent 0.8067329
Regular Market Day High 28.74
Regular Market Day Low 28.73
Regular Market Day Range 28.73 - 28.74
Regular Market Open 27.93
Regular Market Previous Close 28.51
Regular Market Price 28.74
Regular Market Time 1,784,123,503
Regular Market Volume 2,858
Return On Assets 0.011
Revenue Growth 0.058
Revenue Per Share 59.177
Sand P52 Week Change 0.2043345
Sector Healthcare
Sector Disp Healthcare
Sector Key healthcare
Share Holder Rights Risk 8
Shares Outstanding 17,047,789
Shares Percent Shares Out 0.0573
Shares Short 976,649
Shares Short Previous Month Date 1,780,012,800
Shares Short Prior Month 1,165,216
Short Name Claritev Corporation
Short Percent Of Float 0.0947
Short Ratio 7.35
Source Interval 15
State VA
Symbol CTEV
Target High Price 61.0
Target Low Price 22.0
Target Mean Price 36.83333
Target Median Price 35.0
Total Cash 21,327,000
Total Cash Per Share 1.251
Total Debt 4,737,610,240
Total Revenue 978,761,024
Tradeable 0
Trailing Annual Dividend Rate 0.0
Trailing Annual Dividend Yield 0.0
Trailing Eps -16.47
Trailing Peg Ratio None
Triggerable 1
Two Hundred Day Average 33.163
Two Hundred Day Average Change -4.4229984
Two Hundred Day Average Change Percent -0.13337149
Type Disp Equity
Volume 2,858
Website https://www.claritev.com
Zip 22,102